News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cytonet's Liver Cell Therapy May Be Effective In Stabilizing Patients With Urea Cycle Disorders Awaiting Liver Transplant


6/3/2014 8:50:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OTTAWA, Ontario & RALEIGH-DURHAM, N.C.--(BUSINESS WIRE)--New data on Cytonet’s investigational liver cell therapy (LCT) found it may help temporarily stabilize pediatric patients with Urea Cycle Disorders (UCD) while they await liver transplantation. The study was presented at the 2014 Joint Garrod and Canadian Newborn and Child Screening Symposium in Ottawa, Ontario on May 31, 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES